| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | J M White | |
| S E Delos | |||
| H E Park | |||
| L J Earp | |||
| P2860 | cites work | Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion | Q44633908 |
| Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies | Q45742418 | ||
| Temperature dependence of fusion by sendai virus | Q45742427 | ||
| Oligomerization, secretion, and biological function of an anchor-free parainfluenza virus type 2 (PI2) fusion protein | Q45742724 | ||
| Mutations in the glycoprotein of viral haemorrhagic septicaemia virus that affect virulence for fish and the pH threshold for membrane fusion | Q45749135 | ||
| Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis. | Q45752054 | ||
| Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers | Q45773640 | ||
| Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex | Q45785753 | ||
| Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. | Q45828248 | ||
| Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin | Q45829893 | ||
| Maturation of murine leukemia virus env proteins in the absence of other viral proteins | Q45838350 | ||
| A trimeric structural domain of the HIV-1 transmembrane glycoprotein. | Q54155492 | ||
| Evidence for H(+)-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane | Q72068502 | ||
| Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution | Q72165328 | ||
| Influenza hemagglutinin-mediated membrane fusion: influence of receptor binding on the lag phase preceding fusion | Q72528362 | ||
| Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein | Q73270498 | ||
| A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers | Q73309597 | ||
| Acylation of the influenza hemagglutinin modulates fusion activity | Q77165158 | ||
| The protein coat in membrane fusion: lessons from fission | Q77869246 | ||
| HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 | ||
| Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion | Q24538786 | ||
| Fusion of Rous sarcoma virus with host cells does not require exposure to low pH | Q24655687 | ||
| Structure of dengue virus: implications for flavivirus organization, maturation, and fusion | Q24736810 | ||
| The central proline of an internal viral fusion peptide serves two important roles | Q27469628 | ||
| Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion | Q27469690 | ||
| Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E | Q27469713 | ||
| An epitope of the Semliki Forest virus fusion protein exposed during virus-membrane fusion | Q27469752 | ||
| Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E | Q27469788 | ||
| Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. | Q27469927 | ||
| The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains | Q27472848 | ||
| Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. | Q27472865 | ||
| Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins | Q27472931 | ||
| The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex | Q27477706 | ||
| Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH | Q27478446 | ||
| Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus | Q27480753 | ||
| Membrane fusion process of Semliki Forest virus. I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells | Q27485691 | ||
| Viral and cellular membrane fusion proteins | Q34208540 | ||
| Common properties of fusion peptides from diverse systems | Q34293662 | ||
| Viral fusion peptides: a tool set to disrupt and connect biological membranes | Q34293668 | ||
| Caveolae as portals of entry for microbes | Q34328519 | ||
| Soluble receptor potentiates receptor-independent infection by murine coronavirus | Q34329104 | ||
| Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus | Q34330529 | ||
| The machinery for flavivirus fusion with host cell membranes | Q34331567 | ||
| Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein | Q34332519 | ||
| Influenza fusion peptides | Q34332538 | ||
| Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates | Q34341098 | ||
| Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein | Q34347265 | ||
| Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces | Q34352422 | ||
| Covalent modifications of the ebola virus glycoprotein | Q34354004 | ||
| Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics | Q34415921 | ||
| Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion | Q34462207 | ||
| Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide | Q34464572 | ||
| Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain | Q34464923 | ||
| Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites | Q34466260 | ||
| A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. | Q34775394 | ||
| HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation | Q34812952 | ||
| Lipid rafts and assembly of enveloped viruses | Q34852370 | ||
| Human Immunodeficiency Virus Type 1 Env with an Intersubunit Disulfide Bond Engages Coreceptors but Requires Bond Reduction after Engagement To Induce Fusion | Q34977118 | ||
| Insider information: what viruses tell us about endocytosis | Q35189406 | ||
| Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity | Q35566715 | ||
| Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. | Q35833860 | ||
| Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus | Q35849734 | ||
| Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide | Q35853520 | ||
| Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. | Q35853659 | ||
| Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces | Q35875690 | ||
| Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells | Q35890850 | ||
| The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein | Q36001197 | ||
| Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. | Q36201795 | ||
| Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus | Q36214055 | ||
| Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein | Q27486203 | ||
| Structural basis for paramyxovirus-mediated membrane fusion | Q27617867 | ||
| N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil | Q27619272 | ||
| Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket | Q27619965 | ||
| The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion | Q27631011 | ||
| The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH | Q27631190 | ||
| Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin | Q27633701 | ||
| The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles | Q27635152 | ||
| An antibody that prevents the hemagglutinin low pH fusogenic transition | Q27638286 | ||
| Structure of the dengue virus envelope protein after membrane fusion | Q27643009 | ||
| Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus | Q27643010 | ||
| Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation | Q27643140 | ||
| The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution | Q27730234 | ||
| Structure of influenza haemagglutinin at the pH of membrane fusion | Q27730888 | ||
| Core structure of gp41 from the HIV envelope glycoprotein | Q27736064 | ||
| Atomic structure of the ectodomain from HIV-1 gp41 | Q27738021 | ||
| Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 | ||
| Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation | Q27766025 | ||
| Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain | Q27766228 | ||
| Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin | Q27861017 | ||
| Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution | Q28131812 | ||
| The structural biology of type I viral membrane fusion | Q28188215 | ||
| HIV entry and its inhibition | Q28273919 | ||
| Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion | Q28345073 | ||
| Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1 | Q28371845 | ||
| Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements | Q28373387 | ||
| Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion | Q28646673 | ||
| A spring-loaded mechanism for the conformational change of influenza hemagglutinin | Q28646856 | ||
| Structural features of membrane fusion between influenza virus and liposome as revealed by quick-freezing electron microscopy | Q28646869 | ||
| Capture of an early fusion-active conformation of HIV-1 gp41 | Q28646880 | ||
| Mechanisms of viral membrane fusion and its inhibition | Q29616090 | ||
| Membrane fusion | Q29618140 | ||
| Structure and function of sphingolipid- and cholesterol-rich membrane rafts | Q29618518 | ||
| Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry | Q29620710 | ||
| A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype | Q30304191 | ||
| Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity | Q33846366 | ||
| Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41. | Q33847059 | ||
| Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide | Q33850746 | ||
| Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein | Q33851195 | ||
| Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement | Q33852113 | ||
| Specific roles for lipids in virus fusion and exit. Examples from the alphaviruses. | Q33917125 | ||
| Membrane fusion activity of influenza virus. | Q33927846 | ||
| Role of the N-terminal peptides of viral envelope proteins in membrane fusion. | Q33933461 | ||
| Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion | Q33934074 | ||
| Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein | Q34043702 | ||
| Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. | Q34069549 | ||
| Observation of a membrane fusion intermediate structure | Q34149361 | ||
| Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity | Q41071200 | ||
| The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores | Q41093333 | ||
| Entry of Semliki forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection. | Q41133527 | ||
| A new mechanism for the neutralization of enveloped viruses by antiviral antibody | Q41352659 | ||
| Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion. | Q41554310 | ||
| Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones | Q41565125 | ||
| Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus | Q41630846 | ||
| Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity | Q41639247 | ||
| What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). | Q41658185 | ||
| The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes | Q41702321 | ||
| The pH independence of mammalian retrovirus infection | Q41738977 | ||
| pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane | Q41764642 | ||
| A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41 | Q42598413 | ||
| Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system | Q42997821 | ||
| Fusion of enveloped viruses with cells and liposomes. Activity and inactivation | Q43635160 | ||
| Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring. | Q43945296 | ||
| Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes | Q44077405 | ||
| Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study. | Q44184585 | ||
| VSV transmembrane domain (TMD) peptide promotes PEG-mediated fusion of liposomes in a conformationally sensitive fashion | Q44244220 | ||
| Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein | Q44373009 | ||
| Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. | Q44602073 | ||
| Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein | Q30306131 | ||
| The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition | Q30306248 | ||
| Structure and function of membrane fusion peptides | Q30310337 | ||
| The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH. | Q30310511 | ||
| Thermodynamics of fusion peptide-membrane interactions | Q30310922 | ||
| Leash in the groove mechanism of membrane fusion | Q30311919 | ||
| Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein | Q30433973 | ||
| Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines | Q30441948 | ||
| Specific single or double proline substitutions in the "spring-loaded" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion activity | Q30442103 | ||
| Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41 | Q30442126 | ||
| Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein | Q30442135 | ||
| Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion | Q30442161 | ||
| Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers | Q30442203 | ||
| Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity | Q30452569 | ||
| New insights into the spring-loaded conformational change of influenza virus hemagglutinin | Q30452958 | ||
| Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein. | Q30453530 | ||
| Receptor-triggered membrane association of a model retroviral glycoprotein | Q30454419 | ||
| Virus-cell and cell-cell fusion | Q30469833 | ||
| Peptide and non-peptide HIV fusion inhibitors | Q30831361 | ||
| Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells | Q30865013 | ||
| Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage | Q31454800 | ||
| The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding | Q31954340 | ||
| Structural basis for membrane fusion by enveloped viruses | Q33637921 | ||
| Rabies virus-induced membrane fusion | Q33637927 | ||
| pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion. | Q33652712 | ||
| A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. | Q33654081 | ||
| A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes | Q33786094 | ||
| Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity | Q33799995 | ||
| Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity | Q33812739 | ||
| Conformational intermediates and fusion activity of influenza virus hemagglutinin. | Q33813444 | ||
| Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions | Q33815821 | ||
| Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. | Q33815984 | ||
| Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. | Q33821928 | ||
| Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus. | Q36237272 | ||
| Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events | Q36237488 | ||
| A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit | Q36254866 | ||
| Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates | Q36256359 | ||
| pH-dependent fusion between the Semliki Forest virus membrane and liposomes | Q36392548 | ||
| Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. | Q36620954 | ||
| Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein | Q36629882 | ||
| Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport | Q36632361 | ||
| pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry | Q36633601 | ||
| Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. | Q36634800 | ||
| Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin | Q36700712 | ||
| A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity | Q36756570 | ||
| Influenza hemagglutinin is spring-loaded by a metastable native conformation | Q36809584 | ||
| The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion | Q36906696 | ||
| Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion | Q37712954 | ||
| Tight binding of influenza virus hemagglutinin to its receptor interferes with fusion pore dilation | Q38360836 | ||
| Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid | Q38462263 | ||
| Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. | Q39532421 | ||
| An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity | Q39590982 | ||
| Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore | Q39592707 | ||
| Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion | Q39592728 | ||
| Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion | Q39604047 | ||
| Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells | Q39683422 | ||
| Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion | Q39732657 | ||
| Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation | Q39752831 | ||
| Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity. | Q39869009 | ||
| Mutations in the putative fusion peptide of Semliki Forest virus affect spike protein oligomerization and virus assembly. | Q39869725 | ||
| Fusion of bovine leukemia virus with target cells monitored by R18 fluorescence and PCR assays | Q39877869 | ||
| Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein | Q39879338 | ||
| Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes | Q39881687 | ||
| Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains | Q40045940 | ||
| Stalk model of membrane fusion: solution of energy crisis | Q40201228 | ||
| Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulation | Q40209529 | ||
| Alphavirus and flavivirus glycoproteins: structures and functions | Q40541050 | ||
| Membrane fusion and the alphavirus life cycle | Q40551613 | ||
| Pre-transmembrane sequence of Ebola glycoprotein. Interfacial hydrophobicity distribution and interaction with membranes. | Q40568440 | ||
| Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement | Q40612986 | ||
| HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains | Q40690112 | ||
| Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion | Q40705636 | ||
| Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. | Q40705642 | ||
| Identification of R-peptides in envelope proteins of C-type retroviruses | Q40709996 | ||
| Paramyxovirus fusion: a hypothesis for changes | Q40767649 | ||
| Endocytic entry of HIV-1. | Q40855363 | ||
| Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation | Q40885459 | ||
| Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion | Q40981026 | ||
| A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. | Q41016283 | ||
| P304 | page(s) | 25-66 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | The many mechanisms of viral membrane fusion proteins | |
| P478 | volume | 285 |
| Q39788993 | 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses |
| Q27305097 | A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus |
| Q93155572 | A Fusion Peptide in the Spike Protein of MERS Coronavirus |
| Q39397313 | A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus |
| Q27485479 | A Virus-Encoded Cell–Cell Fusion Machine Dependent on Surrogate Adhesins |
| Q36747975 | A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity |
| Q34492100 | A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism |
| Q37018423 | A lipid-protein hybrid model for tight junction |
| Q24537580 | A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes |
| Q36315194 | A novel zinc-binding domain is essential for formation of the functional Junín virus envelope glycoprotein complex |
| Q64114604 | A proline insertion-deletion in the spike glycoprotein fusion peptide of mouse hepatitis virus strongly alters neuropathology |
| Q31051453 | A putative cell surface receptor for white spot syndrome virus is a member of a transporter superfamily |
| Q30351377 | A review of vaccine research and development: human acute respiratory infections. |
| Q36483815 | A single-amino-acid substitution in the TvbS1 receptor results in decreased susceptibility to infection by avian sarcoma and leukosis virus subgroups B and D and resistance to infection by subgroup E in vitro and in vivo |
| Q34905189 | Alphavirus Entry and Membrane Fusion |
| Q37145184 | Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. |
| Q36402028 | Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion |
| Q34435102 | Analysis of the pH requirement for membrane fusion of different isolates of the paramyxovirus parainfluenza virus 5. |
| Q31053897 | Analysis of the subunit stoichiometries in viral entry |
| Q36812295 | Anionic lipids are required for vesicular stomatitis virus G protein-mediated single particle fusion with supported lipid bilayers |
| Q39871099 | Aquareovirus effects syncytiogenesis by using a novel member of the FAST protein family translated from a noncanonical translation start site |
| Q41625896 | Architecture of the SARS coronavirus prefusion spike |
| Q38294473 | Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion |
| Q37982058 | Association of influenza virus proteins with membrane rafts. |
| Q40220827 | Avian infectious bronchitis virus enters cells via the endocytic pathway |
| Q37896455 | Bio-inspired, bioengineered and biomimetic drug delivery carriers |
| Q42042006 | Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein |
| Q27491027 | Cell Type-Specific Recognition of Human Metapneumoviruses (HMPVs) by Retinoic Acid-Inducible Gene I (RIG-I) and TLR7 and Viral Interference of RIG-I Ligand Recognition by HMPV-B1 Phosphoprotein |
| Q37839350 | Cell entry of enveloped viruses. |
| Q40159983 | Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA. |
| Q38873612 | Ceramide formation mediated by acid sphingomyelinase facilitates endosomal escape of caliciviruses. |
| Q27486787 | Changing the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis Virus |
| Q27478061 | Characterization of a Structural Intermediate of Flavivirus Membrane Fusion |
| Q37256710 | Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide |
| Q33987545 | Characterization of an alternate form of Newcastle disease virus fusion protein |
| Q39304996 | Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. |
| Q92555758 | Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes |
| Q36321675 | Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. |
| Q34789408 | Class III viral membrane fusion proteins |
| Q47234337 | Cleavage of the C-terminal fragment of reovirus μ1 is required for optimal infectivity |
| Q27487953 | Closing the door on flaviviruses: Entry as a target for antiviral drug design |
| Q27302420 | Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion |
| Q41902866 | Conserved leucines in N-terminal heptad repeat HR1 of envelope fusion protein F of group II nucleopolyhedroviruses are important for correct processing and essential for fusogenicity |
| Q27477542 | Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites |
| Q27644356 | Crystal Structures of Major Envelope Proteins VP26 and VP28 from White Spot Syndrome Virus Shed Light on Their Evolutionary Relationship |
| Q37157429 | Cytoskeleton reorganization in influenza hemagglutinin-initiated syncytium formation |
| Q27490433 | Dealing with low pH: entry and exit of alphaviruses and flaviviruses |
| Q41666446 | Determining the ratio of the Gaussian curvature and bending elastic moduli of phospholipids from Q(II) phase unit cell dimensions |
| Q36986553 | Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses |
| Q47317755 | Dissection of the fusion machine of SARS-coronavirus. |
| Q27485039 | Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion |
| Q33938568 | Endocytosis of viruses and bacteria |
| Q28588877 | Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection |
| Q110951449 | Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart |
| Q33415477 | Enhanced fusion pore expansion mediated by the trans-acting Endodomain of the reovirus FAST proteins |
| Q99625242 | Entry Inhibitors: Efficient Means to Block Viral Infection |
| Q41924449 | Entry of Newcastle Disease Virus into the host cell: role of acidic pH and endocytosis |
| Q30603656 | Entry of a novel marine DNA virus, Singapore grouper iridovirus, into host cells occurs via clathrin-mediated endocytosis and macropinocytosis in a pH-dependent manner |
| Q38123993 | Entry of rhabdoviruses into animal cells |
| Q36898654 | Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection. |
| Q39969606 | Equine arteritis virus is delivered to an acidic compartment of host cells via clathrin-dependent endocytosis |
| Q30400098 | Evolutionary analyses on the HA gene ofpandemic H1N1/09: early findings |
| Q37234907 | Expression of Ebolavirus glycoprotein on the target cells enhances viral entry |
| Q33883443 | Features of a spatially constrained cystine loop in the p10 FAST protein ectodomain define a new class of viral fusion peptides |
| Q40220873 | Fluorescence dequenching assays of coronavirus fusion |
| Q27477615 | Functions of the Stem Region of the Semliki Forest Virus Fusion Protein during Virus Fusion and Assembly |
| Q40096466 | Fusion induced by a class II viral fusion protein, semliki forest virus E1, is dependent on the voltage of the target cell |
| Q30532780 | Fusion-pore expansion during syncytium formation is restricted by an actin network |
| Q36483892 | Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations |
| Q64089409 | Genes involved in mitochondrial biogenesis and function may not show synchronised responses to mitochondria in shell gland of laying chickens under infectious bronchitis virus challenge |
| Q40498438 | Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Junín arenavirus envelope glycoprotein |
| Q34695284 | Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009. |
| Q30499676 | HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes. |
| Q35658146 | Hendra and nipah infection: pathology, models and potential therapies |
| Q35182834 | Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion |
| Q30448708 | Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate |
| Q33843108 | Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway |
| Q42246556 | Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion |
| Q36540164 | Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity |
| Q21558779 | IFITM proteins restrict viral membrane hemifusion |
| Q34651454 | Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins |
| Q37384933 | Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex |
| Q34963154 | Inhibition of Ebola virus entry by a C-peptide targeted to endosomes |
| Q24814238 | Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein |
| Q35101317 | Inhibition of hendra virus fusion. |
| Q34434940 | Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes |
| Q28294996 | Inner/Outer nuclear membrane fusion in nuclear pore assembly: biochemical demonstration and molecular analysis |
| Q33622464 | Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability |
| Q38768365 | Integrin αvβ1 Modulation Affects Subtype B Avian Metapneumovirus Fusion Protein-mediated Cell-Cell Fusion and Virus Infection |
| Q27490540 | Interactions and Oligomerization of Hantavirus Glycoproteins |
| Q37067907 | Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission. |
| Q61818410 | Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes |
| Q92242558 | Intracellular Vesicle Fusion Requires a Membrane-Destabilizing Peptide Located at the Juxtamembrane Region of the v-SNARE |
| Q35549868 | Intracellular curvature-generating proteins in cell-to-cell fusion. |
| Q35422927 | Intronic deletions of tva receptor gene decrease the susceptibility to infection by avian sarcoma and leukosis virus subgroup A. |
| Q36483877 | Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry. |
| Q34507126 | Ligand-induced and nonfusogenic dissolution of a viral membrane |
| Q30476143 | Liposome reconstitution of a minimal protein-mediated membrane fusion machine |
| Q30248743 | MERS-CoV spike protein: Targets for vaccines and therapeutics |
| Q36215318 | Macrophage fusion: the making of osteoclasts and giant cells |
| Q36901510 | Mechanics of membrane fusion |
| Q27027678 | Mechanisms of coronavirus cell entry mediated by the viral spike protein |
| Q98155448 | Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics |
| Q90219290 | Membrane Composition Modulates Fusion by Altering Membrane Properties and Fusion Peptide Structure |
| Q33770433 | Membrane Fusion Involved in Neurotransmission: Glimpse from Electron Microscope and Molecular Simulation |
| Q80516923 | Membrane activity of an amphiphilic alpha-helical membrane-proximal cytoplasmic domain of the MoMuLV envelope glycoprotein |
| Q34221609 | Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tail |
| Q38256285 | Membrane proteins of arterivirus particles: structure, topology, processing and function. |
| Q42280908 | Membrane requirement for folding of the herpes simplex virus 1 gB cytodomain suggests a unique mechanism of fusion regulation |
| Q30437943 | Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion |
| Q40304999 | Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion |
| Q40020345 | Membrane-proximal cytoplasmic domain of Moloney murine leukemia virus envelope tail facilitates fusion |
| Q42689581 | Multifaceted sequence-dependent and -independent roles for reovirus FAST protein cytoplasmic tails in fusion pore formation and syncytiogenesis. |
| Q30478481 | Multiple intermediates in SNARE-induced membrane fusion |
| Q34651205 | Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion |
| Q35754943 | Mutations in the DI-DII Linker of Human Parainfluenza Virus Type 3 Fusion Protein Result in Diminished Fusion Activity |
| Q38809753 | Mutations in the Leucine Zipper-Like Motif of the Human Parainfluenza Virus 3 Fusion Protein Impair Fusion Activity. |
| Q41921957 | NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion. |
| Q41726816 | NMR structures and localization of the potential fusion peptides and the pre-transmembrane region of SARS-CoV: Implications in membrane fusion. |
| Q43255517 | Nipah virus entry can occur by macropinocytosis |
| Q81504869 | Opinion: Cell entry machines: a common theme in nature? |
| Q38006719 | Palmitoylation of virus proteins |
| Q36346778 | Paramyxovirus membrane fusion: lessons from the F and HN atomic structures |
| Q41855783 | Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. |
| Q45433900 | Pleiotropic mechanisms of virus survival and persistence |
| Q34202362 | Poxvirus multiprotein entry-fusion complex |
| Q37640977 | Poxvirus proteomics and virus-host protein interactions |
| Q36090006 | Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins. |
| Q33373579 | Protein intrinsic disorder toolbox for comparative analysis of viral proteins |
| Q42176996 | Punctuated evolution of influenza virus neuraminidase (A/H1N1) under opposing migration and vaccination pressures |
| Q40229048 | Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit |
| Q30479669 | Rapid membrane fusion of individual virus particles with supported lipid bilayers. |
| Q33263085 | Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy |
| Q34917410 | Reovirus FAST protein transmembrane domains function in a modular, primary sequence-independent manner to mediate cell-cell membrane fusion. |
| Q35128812 | Residue-level resolution of alphavirus envelope protein interactions in pH-dependent fusion |
| Q27481481 | Role of Endocytosis and Low pH in Murine Hepatitis Virus Strain A59 Cell Entry |
| Q40002207 | Role of endocytosis and cathepsin-mediated activation in Nipah virus entry |
| Q30439990 | Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein |
| Q42638118 | Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis |
| Q37033266 | Role of thiol/disulfide exchange in newcastle disease virus entry |
| Q52563510 | Rotation-Activated and Cooperative Zipping Characterize Class I Viral Fusion Protein Dynamics. |
| Q27477540 | Site-Directed Antibodies against the Stem Region Reveal Low pH-Induced Conformational Changes of the Semliki Forest Virus Fusion Protein |
| Q35785110 | Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein |
| Q39462591 | Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein |
| Q30447936 | Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1 |
| Q24649949 | Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses |
| Q29618168 | Structural basis of West Nile virus neutralization by a therapeutic antibody |
| Q27481675 | Structural basis of viral invasion: lessons from paramyxovirus F |
| Q45421033 | Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation |
| Q33855371 | Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein |
| Q27680499 | Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus |
| Q27487974 | Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme |
| Q45416737 | Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein |
| Q40293043 | Subunit stoichiometry of human immunodeficiency virus type 1 envelope glycoprotein trimers during virus entry into host cells |
| Q40165402 | Surface density of the Hendra G protein modulates Hendra F protein-promoted membrane fusion: role for Hendra G protein trafficking and degradation |
| Q42638352 | TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation |
| Q37175177 | Targeted strategies for henipavirus therapeutics |
| Q43181323 | The anti-HIV actions of 7- and 10-substituted camptothecins. |
| Q34545634 | The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells |
| Q37159933 | The biophysical function of pulmonary surfactant |
| Q36585513 | The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes |
| Q34787116 | The final conformation of the complete ectodomain of the HA2 subunit of influenza hemagglutinin can by itself drive low pH-dependent fusion |
| Q37027166 | The growth and potential of human antiviral monoclonal antibody therapeutics. |
| Q40179783 | The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion |
| Q33614501 | The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. |
| Q33930439 | The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion |
| Q41345703 | The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment |
| Q36469974 | The structural basis of paramyxovirus invasion |
| Q27655400 | The structure of a cytolytic alpha-helical toxin pore reveals its assembly mechanism |
| Q34742453 | The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein |
| Q35784690 | Thiol/disulfide exchange is required for membrane fusion directed by the Newcastle disease virus fusion protein |
| Q24538796 | Transmembrane peptides stabilize inverted cubic phases in a biphasic length-dependent manner: implications for protein-induced membrane fusion |
| Q41080258 | Transmembrane proteins are not required for early stages of nuclear envelope assembly |
| Q35947676 | Two distinct low-pH steps promote entry of vaccinia virus |
| Q37714227 | Use of herpes simplex virus and pseudorabies virus chimeric glycoprotein D molecules to identify regions critical for membrane fusion |
| Q33908798 | Vaccinia virus A21 virion membrane protein is required for cell entry and fusion |
| Q35101454 | Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex |
| Q35024254 | Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway |
| Q37238558 | Vaccinia virus strain differences in cell attachment and entry |
| Q24631787 | Viral and developmental cell fusion mechanisms: conservation and divergence |
| Q37941707 | Viral infection: Moving through complex and dynamic cell-membrane structures. |
| Q41812409 | Virosome presents multimodel cancer therapy without viral replication |
| Q29619349 | Virus entry: open sesame |
| Q29620769 | Virus membrane-fusion proteins: more than one way to make a hairpin |
| Q28487427 | Virus neutralisation: new insights from kinetic neutralisation curves |
| Q37681125 | Viruses as vesicular carriers of the viral genome: a functional module perspective. |
| Q63739867 | Zika virus: mapping and reprogramming the entry |
| Q40410440 | pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors |
Search more.